Sign in

Harpreet Saluja

Executive Vice President, Corporate Strategy & Business Development at ECL
Executive

About Harpreet Saluja

Harpreet Saluja, 56, is Executive Vice President, Corporate Strategy & Business Development at Ecolab, appointed in November 2024 and listed among current executive officers in the 2024 Form 10-K . During 2024, Ecolab delivered record performance with reported sales growth of 3%, organic sales growth of 4%, reported operating income margin expansion of 480 bps, and adjusted diluted EPS growth of 28% . In Q3 2025, adjusted diluted EPS rose 13% to $2.07 on organic sales +3%, with segment-level organic growth across Water, Institutional & Specialty, Pest Elimination, and Life Sciences; adjusted TTM EBITDA rose to $3,809.5 million vs. $3,541.5 million a year earlier .

Past Roles

OrganizationRoleYearsStrategic Impact
EcolabEVP, Corporate Strategy & Business DevelopmentNov 2024–Present Senior executive leadership over corporate strategy and business development

External Roles

No external directorships or public-company roles are disclosed for Saluja in Ecolab’s 2024 Form 10-K executive officer listing .

Performance Compensation

Management Incentive Plan (MIP) — Company framework (applies to executive officers)

MetricWeighting example (by role)2024 Target/ThresholdsActual/OutcomePayout mechanicsSource
Adjusted Diluted EPSPrimary measure for all officersMin $5.37; Target $5.82; 140% at $6.12; Max ≥$6.50 $6.65 (above max) Straight-line interpolation to 200% for EPS component
Enterprise Goal (commercial average + EPS)Used for roles with broad P&L impact (e.g., COO, Supply Chain)60% commercial average; 40% EPS Commercial average 123%; EPS 200% → blended 154% Contributes to capped total payout
Business Unit GoalUsed for business unit leaders50% sales growth; 50% operating income growth Example (Institutional): Sales 179%, OI 191% → 185% Adds to capped total payout
Individual GoalsUsed for staff roles (e.g., CFO, Supply Chain)Strategic, qualitative objectives Examples provided for CFO and Supply Chain Weighted at 30% in example roles
Growth & Impact ModifierApplies to officers in aggregate+3%, +6%, +10% or -10% +10% achieved (subject to 200% cap) Incremental modifier capped by plan

Administrative rules include pro-ration for new hires/promotions and eligibility conditions, relevant for executives appointed during the year .

Long-Term Equity Incentives — Company design (applies to executive officers)

Award TypePerformance/VestingTargets/MechanicsOutcome exampleSource
PBRSUsCliff-vest after 3 years; metric = 3-year average organic ROIC; ±10% TSR modifier vs S&P 500 (cap at 200%) 2025–2027 organic ROIC: Threshold 11.8%; Target 16.2%; Max 18.4% Prior cycle (2022–2024) paid 100% at adjusted ROIC result per plan design
Stock Options3-year ratable vesting; 10-year term; strike = average of high/low on grant date Valuation assumptions disclosed (e.g., 12/04/2024 grants: risk-free 4.06%, expected life 6.09 yrs, vol 22.60%, dividend 1.05%) Value realized depends on post-grant share appreciation

Company Performance Reference (for context)

MetricTTM 2024TTM 2025Notes
EBITDA ($mm)$3,796.0 $3,616.2 Reported EBITDA decreased YoY
Adjusted EBITDA ($mm)$3,541.5 $3,809.5 Adjusted EBITDA increased YoY

Equity Ownership & Alignment

  • Stock ownership guidelines require significant ownership and retention until achieved; CEO/CFO/COO must retain 100% of net shares until compliant, other officers 50%; unexercised options and unvested RSUs/PBRSUs do not count toward compliance .
  • Hedging and pledging of Ecolab stock are prohibited for insiders (including executive officers) per Global Insider Trading Policy .
  • Directors and executive officers as a group owned ~0.5% of shares outstanding as of March 11, 2025; individual executive ownership for Saluja is not separately disclosed in the proxy .

Employment Terms

  • Appointment and tenure: Saluja was appointed EVP, Corporate Strategy & Business Development in November 2024 .
  • MIP pro-ration and eligibility: new executive participants are pro-rated in full-month increments, with payments approved post year-end; must be employed on last business day of fiscal year unless retirement/disability/death, with potential pro-rata award .
  • Change-in-control policy (double-trigger): for elected officers, severance equals 2x base salary plus target annual incentive, pro-rata actual annual bonus in year of termination, outplacement, and continued medical/dental for up to 18 months; no single-trigger and no tax gross-ups .
  • “Cause” definition (stock plan): amended in Dec 2024 to include dishonesty/fraud, serious unlawful activity, intentional material duty breaches, material breach of noncompetition/non-solicitation/confidentiality agreements, and substantial failure to perform after notice/opportunity to cure .
  • Clawbacks: Ecolab maintains broader misconduct-based recoupment and NYSE Rule 10D-1 compliant clawback for restatements covering excess incentive-based compensation over prior three fiscal years .
  • Additional severance context: for NEOs, case-by-case negotiated severance for discharge not for cause or constructive discharge may include up to two years’ base salary and target annual cash incentive, with potential pro-rated equity acceleration at Committee discretion; company practice outlines options/PBRSU handling .

Fixed Compensation

Company philosophy sets base salaries within the median range of the size-adjusted competitive market, with annual merit reviews and structured progression for new executives; detailed individual salary/bonus amounts for Saluja are not disclosed in public filings .

Investment Implications

  • Alignment: Ecolab’s executive pay strongly ties variable compensation to multi-year organic ROIC and adjusted EPS, with capped payouts and a TSR modifier, plus strict hedging/pledging prohibitions and ownership/retention guidelines — signaling robust pay-for-performance alignment and governance quality for senior officers including Saluja .
  • Retention risk: As a November 2024 appointee, Saluja’s MIP participation will be pro-rated per plan rules and he is covered by double-trigger CIC economics; these terms mitigate near-term attrition risk while preserving shareholder protections (no single-trigger, no gross-ups) .
  • Execution risk vs. value creation: Corporate results in 2024–2025 show strong adjusted EPS and organic growth momentum with rising adjusted EBITDA; strategy roles tied to growth engines and inorganic initiatives should be evaluated against these metrics in future cycles to assess payout sustainability and insider selling pressure once individual Form 4 activity is observable .

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%